Am. J. Respir. Crit. Care Med., Vol 152, No. 1, Jul 1995, 93-97.
Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension
JE Loyd, MG Butler, TM Foroud, PM Conneally, JA Phillips 3rd and JH Newman
Division of Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
The genetic basis of familial primary pulmonary hypertension (FPPH) is
unknown, but the clinical and pathologic features are the same as in
sporadically occurring primary pulmonary hypertension (PPH). Because few
families with this disease have been reported, the mode of inheritance and
genetic features have not been clearly established. We previously reported
a tendency for decreasing age of onset in subsequent generations of
affected families. The purpose of this study was to examine the pattern of
inheritance in a large number of families in an attempt to find clues to
pathogenesis. From 24 families we studied 429 members, 124 of whom were
known to carry the gene for disease. We constructed cumulative mortality
curves for each gender of the 99 affected individuals. We analyzed gender
ratios of progeny of affected members and carriers and compared age at
death of affected members by generation. More females (160) than males
(122) were born to persons carrying the gene, p < 0.01, suggesting
selective wastage of male fetuses or an abnormal primary sex ratio. Genetic
anticipation was confirmed; the age at death was 45.6 +/- 14.5 versus 36.3
+/- 12.6 versus 24.2 +/- 11 standard deviation (SD) years in successive
generations, p < 0.05. Five cases of male-to-male transmission were
observed, excluding X-linkage. Age at death was the same for males and
females. More females had the gene (84 females, 40 males) and more females
with the gene developed disease (72 of 84 females [86%] versus 27 of 40
males [68%]). The disease has highly variable penetrance among
families.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
S G Haworth
The management of pulmonary hypertension in children
Arch. Dis. Child.,
July 1, 2008;
93(7):
620 - 625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Sztrymf, F. Coulet, B. Girerd, A. Yaici, X. Jais, O. Sitbon, D. Montani, R. Souza, G. Simonneau, F. Soubrier, et al.
Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 Mutation
Am. J. Respir. Crit. Care Med.,
June 15, 2008;
177(12):
1377 - 1383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yang, R. J. Davies, M. Southwood, L. Long, X. Yang, A. Sobolewski, P. D. Upton, R. C. Trembath, and N. W. Morrell
Mutations in Bone Morphogenetic Protein Type II Receptor Cause Dysregulation of Id Gene Expression in Pulmonary Artery Smooth Muscle Cells: Implications for Familial Pulmonary Arterial Hypertension
Circ. Res.,
May 23, 2008;
102(10):
1212 - 1221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Klinger
Pulmonary Arterial Hypertension: An Overview
Seminars in Cardiothoracic and Vascular Anesthesia,
June 1, 2007;
11(2):
96 - 103.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Edelman
Clinical Presentation, Differential Diagnosis, and Vasodilator Testing of Pulmonary Hypertension
Seminars in Cardiothoracic and Vascular Anesthesia,
June 1, 2007;
11(2):
110 - 118.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Laney, T. De Marco, J. S. Peters, M. Malloy, C. Teehankee, P. S. Moore, and Y. Chang
Kaposi Sarcoma-Associated Herpesvirus and Primary and Secondary Pulmonary Hypertension
Chest,
March 1, 2005;
127(3):
762 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Rashid and D Ivy
Severe paediatric pulmonary hypertension: new management strategies
Arch. Dis. Child.,
January 1, 2005;
90(1):
92 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Bull, C. D. Coldren, M. Moore, S. M. Sotto-Santiago, D. V. Pham, S. P. Nana-Sinkam, N. F. Voelkel, and M. W. Geraci
Gene Microarray Analysis of Peripheral Blood Cells in Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med.,
October 15, 2004;
170(8):
911 - 919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. McGoon, D. Gutterman, V. Steen, R. Barst, D. C. McCrory, T. A. Fortin, and J. E. Loyd
Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines
Chest,
July 1, 2004;
126(1_suppl):
14S - 34S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Newman, R. C. Trembath, J. A. Morse, E. Grunig, J. E. Loyd, S. Adnot, F. Coccolo, C. Ventura, J. A. Phillips III, J. A. Knowles, et al.
Genetic basis of pulmonary arterial hypertension: Current understanding and future directions
J. Am. Coll. Cardiol.,
June 16, 2004;
43(12_Suppl_S):
33S - 39S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fujita, R. J. Mason, C. Cool, J. M. Shannon, N. Hara, and K. A. Fagan
Pulmonary hypertension in TNF-alpha -overexpressing mice is associated with decreased VEGF gene expression
J Appl Physiol,
December 1, 2002;
93(6):
2162 - 2170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Chatterjee, T. De Marco, and J. S. Alpert
Pulmonary Hypertension: Hemodynamic Diagnosis and Management
Arch Intern Med,
September 23, 2002;
162(17):
1925 - 1933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Humbert and R.C. Trembath
Genetics of pulmonary hypertension: from bench to bedside
Eur. Respir. J.,
September 1, 2002;
20(3):
741 - 749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Loyd
Genetics and Gene Expression in Pulmonary Hypertension : Parker B. Francis Lecture
Chest,
March 1, 2002;
121(2007):
46S - 50S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Morse
Bone Morphogenetic Protein Receptor 2 Mutations in Pulmonary Hypertension
Chest,
March 1, 2002;
121(2007):
50S - 53S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
British Cardiac Society Guidelines and Medical Pra
Recommendations on the management of pulmonary hypertension in clinical practice
Heart,
September 1, 2001;
86(90001):
i1 - 13.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Newman, L. Wheeler, K. B. Lane, E. Loyd, R. Gaddipati, J. A. Phillips III, and J. E. Loyd
Mutation in the Gene for Bone Morphogenetic Protein Receptor II as a Cause of Primary Pulmonary Hypertension in a Large Kindred
N. Engl. J. Med.,
August 2, 2001;
345(5):
319 - 324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Loscalzo
Genetic Clues to the Cause of Primary Pulmonary Hypertension
N. Engl. J. Med.,
August 2, 2001;
345(5):
367 - 371.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J R Thomson and R C Trembath
Primary pulmonary hypertension: the pressure rises for a gene
J. Clin. Pathol.,
December 1, 2000;
53(12):
899 - 903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Archer and S. Rich
Primary Pulmonary Hypertension : A Vascular Biology and Translational Research "Work in Progress"
Circulation,
November 28, 2000;
102(22):
2781 - 2791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Grunig, B. Janssen, D. Mereles, U. Barth, M. M. Borst, I. R. Vogt, C. Fischer, H. Olschewski, H. F. Kuecherer, and W. Kubler
Abnormal Pulmonary Artery Pressure Response in Asymptomatic Carriers of Primary Pulmonary Hypertension Gene
Circulation,
September 5, 2000;
102(10):
1145 - 1150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Fishman
Aminorex to Fen/Phen : An Epidemic Foretold
Circulation,
January 12, 1999;
99(1):
156 - 161.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G Haworth
Primary pulmonary hypertension in childhood
Arch. Dis. Child.,
November 1, 1998;
79(5):
452 - 455.
[Full Text]
|
 |
|

|
 |

|
 |
 
J. H. Morse, A. C. Jones, R. J. Barst, S. E. Hodge, K. C. Wilhelmsen, and T. G. Nygaard
Mapping of Familial Primary Pulmonary Hypertension Locus (PPH1) to Chromosome 2q31-q32
Circulation,
June 17, 1997;
95(12):
2603 - 2606.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. J. Rubin
Primary Pulmonary Hypertension
N. Engl. J. Med.,
January 9, 1997;
336(2):
111 - 117.
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 American Thoracic Society
|
|
|